title: Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo.
abstract: Hydrazine hepatotoxicity in vivo, as manifested by triglyceride accumulation, depletion of ATP and reduced glutathione (GSH) was shown to be dose related. The effect of pretreatment of rats with various inhibitors and inducers of cytochrome P450 on these dose-response relationships was investigated. Pretreatment with the inhibitor piperonyl butoxide increased triglyceride accumulation whereas pretreatment with the inducers phenobarbital and beta-naphthoflavone (BNF) resulted in reduced triglyceride accumulation. Pretreatment with the inducers acetone and isoniazid also enhanced triglyceride accumulation. Only phenobarbital pretreatment also significantly reduced GSH and ATP depletion. A linear correlation was found between hepatic glutathione and ATP levels in non-pretreated animals given various doses of hydrazine. However, exponential relationships were found between hepatic triglycerides and both hepatic ATP and glutathione. The results suggest that i) the hepatotoxicity of hydrazine can be modulated by inducing or inhibiting particular isoenzymes of cytochrome P450, ii) ATP and GSH depletion may not be directly involved in the development of fatty liver.
authors.affiliation: Toxicology Department, School of Pharmacy, University of London, UK.
authors.forename: A M
authors.initials: AM
authors.lastname: Jenner
authors.forename: J A
authors.initials: JA
authors.lastname: Timbrell
mesh_terms: D000096:Acetone / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001571:Benzoflavones / Q000494:pharmacology; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000187:drug effects*; D004790:Enzyme Induction / Q000187:drug effects; D005978:Glutathione / Q000378:metabolism; D006834:Hydrazines / Q000378:metabolism / Q000633:toxicity*; D007538:Isoniazid / Q000494:pharmacology; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology; D010882:Piperonyl Butoxide / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014280:Triglycerides / Q000378:metabolism; D019324:beta-Naphthoflavone
chemical_list: D001571:Benzoflavones; D065607:Cytochrome P-450 Enzyme Inhibitors; D006834:Hydrazines; D014280:Triglycerides; D000096:Acetone; C029424:hydrazine; D019324:beta-Naphthoflavone; D000255:Adenosine Triphosphate; D003577:Cytochrome P-450 Enzyme System; D005978:Glutathione; D010882:Piperonyl Butoxide; D007538:Isoniazid; D010634:Phenobarbital